| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C0001792> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C0003451> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C0019993> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C0022277> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C0026062> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C0032310> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C0035363> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C0036232> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C0036859> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C0063717> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C0085415> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C0086287> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C0086582> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C0087113> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C0205847> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C0206750> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C0521117> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C0600378> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C1609165> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C2740854> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C2830231> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C2985546> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C3272237> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C3694279> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C3850123> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C4704925> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C5226663> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C5227770> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C5227771> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C5227772> <https://research.tib.eu/covid-19/entity/32652164_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Infectious Diseases Unit, ASST Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore 3, 20162 Milan, Italy. Electronic address: roberto.rossotti@ospedaleniguarda.it.\', \'Infectious Diseases Unit, ASST Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore 3, 20162 Milan, Italy.\', \'Rheumatology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.\', \'Healthcare Management Department, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.\', \'Department of Anaesthesia and Critical Care, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy; School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.\', \'Department of Anaesthesia and Critical Care, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.\', \'Emergency Department, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.\', \'Internal Medicine Department, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.\', \'Chemical-Clinical and Microbiological Analysis, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.\', \'Chemical-Clinical and Microbiological Analysis, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Oncology and Oncohematology, University of Milan, Milan, Italy.\', \'Pneumology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Baiguera_Chiara> <https://research.tib.eu/covid-19/entity/Basile_Andriano> <https://research.tib.eu/covid-19/entity/Bellone_Andrea> <https://research.tib.eu/covid-19/entity/Bottiroli_Maurizio> <https://research.tib.eu/covid-19/entity/Colombo_Fabrizio> <https://research.tib.eu/covid-19/entity/Corradin_Matteo> <https://research.tib.eu/covid-19/entity/Epis_Oscar_Massimiliano> <https://research.tib.eu/covid-19/entity/Fumagalli_Roberto> <https://research.tib.eu/covid-19/entity/Merli_Marco> <https://research.tib.eu/covid-19/entity/Mondino_Michele> <https://research.tib.eu/covid-19/entity/Moreno_Mauro> <https://research.tib.eu/covid-19/entity/Pastori_Stefano> <https://research.tib.eu/covid-19/entity/Perno_Carlo_Federico> <https://research.tib.eu/covid-19/entity/Puoti_Massimo> <https://research.tib.eu/covid-19/entity/Rossotti_Roberto> <https://research.tib.eu/covid-19/entity/Ruggeri_Ruggero> <https://research.tib.eu/covid-19/entity/Tarsia_Paolo> <https://research.tib.eu/covid-19/entity/Travi_Giovanna> <https://research.tib.eu/covid-19/entity/Ughi_Nicola>
?:doi	<https://research.tib.eu/covid-19/entity/S0163-4453%2820%2930467-910.1016/j.jinf.2020.07.008>
?:doi	S0163-4453(20)30467-910.1016/j.jinf.2020.07.008
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Comparative_Study> <https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t>
?:journal	The Journal of infection
is ?:pmid of	<https://research.tib.eu/covid-19/entity/32652164>
?:pmid	<https://research.tib.eu/covid-19/entity/32652164>
?:pmid	32652164
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
?:title	Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2020

Property

Value

is ?:annotates of

?:authorAffiliation

[\'Infectious Diseases Unit, ASST Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore 3, 20162 Milan, Italy. Electronic address: roberto.rossotti@ospedaleniguarda.it.\', \'Infectious Diseases Unit, ASST Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore 3, 20162 Milan, Italy.\', \'Rheumatology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.\', \'Healthcare Management Department, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.\', \'Department of Anaesthesia and Critical Care, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy; School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.\', \'Department of Anaesthesia and Critical Care, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.\', \'Emergency Department, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.\', \'Internal Medicine Department, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.\', \'Chemical-Clinical and Microbiological Analysis, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.\', \'Chemical-Clinical and Microbiological Analysis, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Oncology and Oncohematology, University of Milan, Milan, Italy.\', \'Pneumology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.\']

?:citedBy

-1

?:creator

?:doi

<https://research.tib.eu/covid-19/entity/S0163-4453%2820%2930467-910.1016/j.jinf.2020.07.008>

?:doi

S0163-4453(20)30467-910.1016/j.jinf.2020.07.008

?:hasPublicationType

?:journal

The Journal of infection

is ?:pmid of

<https://research.tib.eu/covid-19/entity/32652164>

?:pmid

<https://research.tib.eu/covid-19/entity/32652164>

?:pmid

32652164

?:publication_isRelatedTo_Disease

<https://research.tib.eu/covid-19/entity/Covid-19>

?:rankingScore_SJR

-1.0

?:rankingScore_hIndex

-1

?:title

Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis.

?:type

?:year

2020

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/32652164>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/32652164>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

Metadata